Matches in SemOpenAlex for { <https://semopenalex.org/work/W1921213804> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W1921213804 endingPage "569" @default.
- W1921213804 startingPage "562" @default.
- W1921213804 abstract "Patients with atrial fibrillation requiring maintenance haemodialysis are at increased risk of ischaemic stroke and bleeds. Currently, vitamin K antagonists such as warfarin are predominantly used in these patients as limited data are available on the use of non-vitamin K oral anticoagulants, including dabigatran etexilate (dabigatran). Dabigatran is approximately 85 % renally eliminated, thus, its half-life is prolonged in renal impairment. This study simulated the doseexposure relationship of dabigatran in patients undergoing haemodialysis. Dabigatran exposure was modelled at once- and twice-daily doses of 75 mg, 110 mg and 150 mg and at variations in non-renal clearance and dialysis settings. Resultant dose exposure (area under the curve [AUC]) was compared with values simulated from typical patients in the RE-LY® trial (based on a previously characterised pharmacometric model). In this simulation, all twice-daily dosages resulted in exposures above those simulated from typical RE-LY patients (1.5- to 3.3-fold increase in AUC) and thus may not be optimal for use in haemodialysis patients. However, dabigatran doses of 75 mg or 110 mg once daily produced exposures comparable to those simulated in typical RE-LY patients (-13.3 and +4.4 %, respectively). Of patient and dialysis variables, non-renal clearance had the highest impact on exposure (≤ 30.8 % change). These data could potentially inform dose selection in patients undergoing maintenance haemodialysis and the findings warrant investigation in future clinical trials." @default.
- W1921213804 created "2016-06-24" @default.
- W1921213804 creator A5008080119 @default.
- W1921213804 creator A5016763799 @default.
- W1921213804 creator A5019355371 @default.
- W1921213804 creator A5038205675 @default.
- W1921213804 creator A5061395731 @default.
- W1921213804 date "2016-01-01" @default.
- W1921213804 modified "2023-10-16" @default.
- W1921213804 title "Dabigatran treatment simulation in patients undergoing maintenance haemodialysis" @default.
- W1921213804 cites W1587492601 @default.
- W1921213804 cites W1971220180 @default.
- W1921213804 cites W1982179895 @default.
- W1921213804 cites W1997854923 @default.
- W1921213804 cites W2048512819 @default.
- W1921213804 cites W2050900880 @default.
- W1921213804 cites W2076917317 @default.
- W1921213804 cites W2092332131 @default.
- W1921213804 cites W2113446992 @default.
- W1921213804 cites W2131626932 @default.
- W1921213804 cites W2136489990 @default.
- W1921213804 cites W2138300560 @default.
- W1921213804 cites W2142970733 @default.
- W1921213804 cites W2158813407 @default.
- W1921213804 cites W2203036336 @default.
- W1921213804 cites W4205645630 @default.
- W1921213804 doi "https://doi.org/10.1160/th15-07-0531" @default.
- W1921213804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26467062" @default.
- W1921213804 hasPublicationYear "2016" @default.
- W1921213804 type Work @default.
- W1921213804 sameAs 1921213804 @default.
- W1921213804 citedByCount "9" @default.
- W1921213804 countsByYear W19212138042016 @default.
- W1921213804 countsByYear W19212138042018 @default.
- W1921213804 countsByYear W19212138042019 @default.
- W1921213804 countsByYear W19212138042020 @default.
- W1921213804 countsByYear W19212138042023 @default.
- W1921213804 crossrefType "journal-article" @default.
- W1921213804 hasAuthorship W1921213804A5008080119 @default.
- W1921213804 hasAuthorship W1921213804A5016763799 @default.
- W1921213804 hasAuthorship W1921213804A5019355371 @default.
- W1921213804 hasAuthorship W1921213804A5038205675 @default.
- W1921213804 hasAuthorship W1921213804A5061395731 @default.
- W1921213804 hasConcept C126322002 @default.
- W1921213804 hasConcept C2776301958 @default.
- W1921213804 hasConcept C2776704044 @default.
- W1921213804 hasConcept C2778661090 @default.
- W1921213804 hasConcept C2778810321 @default.
- W1921213804 hasConcept C2779161974 @default.
- W1921213804 hasConcept C2779978075 @default.
- W1921213804 hasConcept C2780638905 @default.
- W1921213804 hasConcept C42219234 @default.
- W1921213804 hasConcept C71924100 @default.
- W1921213804 hasConceptScore W1921213804C126322002 @default.
- W1921213804 hasConceptScore W1921213804C2776301958 @default.
- W1921213804 hasConceptScore W1921213804C2776704044 @default.
- W1921213804 hasConceptScore W1921213804C2778661090 @default.
- W1921213804 hasConceptScore W1921213804C2778810321 @default.
- W1921213804 hasConceptScore W1921213804C2779161974 @default.
- W1921213804 hasConceptScore W1921213804C2779978075 @default.
- W1921213804 hasConceptScore W1921213804C2780638905 @default.
- W1921213804 hasConceptScore W1921213804C42219234 @default.
- W1921213804 hasConceptScore W1921213804C71924100 @default.
- W1921213804 hasIssue "03" @default.
- W1921213804 hasLocation W19212138041 @default.
- W1921213804 hasLocation W19212138042 @default.
- W1921213804 hasOpenAccess W1921213804 @default.
- W1921213804 hasPrimaryLocation W19212138041 @default.
- W1921213804 hasRelatedWork W2049310472 @default.
- W1921213804 hasRelatedWork W2292941107 @default.
- W1921213804 hasRelatedWork W2321904733 @default.
- W1921213804 hasRelatedWork W2409384620 @default.
- W1921213804 hasRelatedWork W2604378539 @default.
- W1921213804 hasRelatedWork W2789710191 @default.
- W1921213804 hasRelatedWork W2793392713 @default.
- W1921213804 hasRelatedWork W3173880122 @default.
- W1921213804 hasRelatedWork W4319019627 @default.
- W1921213804 hasRelatedWork W168870552 @default.
- W1921213804 hasVolume "115" @default.
- W1921213804 isParatext "false" @default.
- W1921213804 isRetracted "false" @default.
- W1921213804 magId "1921213804" @default.
- W1921213804 workType "article" @default.